Conflict of interest disclosure: The Institute for Medical Immunology is sponsored by GSKBiologicals (Rixensart, Belgium) and Michel Goldman serves as consultant for GSKBiologicals and OM-Pharma (Meyrin, Switzerland).
Sublingual immunotherapy: the quest for innovative adjuvants
Article first published online: 21 AUG 2008
© 2008 The Author. Journal compilation © 2008 Blackwell Publishing Ltd
Clinical & Experimental Allergy
Volume 38, Issue 11, pages 1705–1706, November 2008
How to Cite
Goldman, M. (2008), Sublingual immunotherapy: the quest for innovative adjuvants. Clinical & Experimental Allergy, 38: 1705–1706. doi: 10.1111/j.1365-2222.2008.03090.x
- Issue published online: 22 OCT 2008
- Article first published online: 21 AUG 2008
Options for accessing this content:
- If you have access to this content through a society membership, please first log in to your society website.
- If you would like institutional access to this content, please recommend the title to your librarian.
- Login via other institutional login options http://onlinelibrary.wiley.com/login-options.
- You can purchase online access to this Article for a 24-hour period (price varies by title)
- New Users: Please register, then proceed to purchase the article.
Login via OpenAthens
Search for your institution's name below to login via Shibboleth.
Registered Users please login:
- Access your saved publications, articles and searches
- Manage your email alerts, orders and subscriptions
- Change your contact information, including your password
Please register to:
- Save publications, articles and searches
- Get email alerts
- Get all the benefits mentioned below!
Patients and/or caregivers may access this content for use in relation to their own personal healthcare or that of a family member only. Terms and conditions will apply.